General Information of the Compound
| Compound ID |
CP0198575
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[1-[[(5R)-5-amino-5,6,7,8-tetrahydronaphthalen-2-yl]methyl]piperidin-4-yl]-N-(4-chloro-3-methoxyphenyl)propanamide;2,2,2-trifluoroacetic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C28H35ClF3N3O4
|
||||||||||||||||||
| Molecular Weight |
570.052
|
||||||||||||||||||
| Canonical SMILES |
OC(=O)C(F)(F)F.CCC(=O)N(C1CCN(Cc2ccc3[C@H](N)CCCc3c2)CC1)c1ccc(Cl)c(OC)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H34ClN3O2.C2HF3O2/c1-3-26(31)30(21-8-10-23(27)25(16-21)32-2)20-11-13-29(14-12-20)17-18-7-9-22-19(15-18)5-4-6-24(22)28;3-2(4,5)1(6)7/h7-10,15-16,20,24H,3-6,11-14,17,28H2,1-2H3;(H,6,7)/t24-;/m1./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
BLUAULCZMUXBHI-GJFSDDNBSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Protein ID: PT01549, Mu-type opioid receptor